KIRAN MAZUMDAR SHAW
Latest launches to help Biocon reach billion-dollar biosimilar sales by 2022: Kiran Mazumdar Shaw
Herceptin is a biosimilar trastuzumab is going to be a major launch for both Biocon & Mylan.
India Inc neither anti-national nor anti-government: Kiran Mazumdar Shaw
Shaw, who had earlier said the government treated India Inc as "pari...
PM Narendra Modi to address Assocham AGM on December 20
The prime minister's address at the industry event - 'New India Aspiring for a USD 5 ...
Biocon elevates Siddharth Mittal as CEO and joint MD
Mittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30.
Kiran Mazumdar-Shaw gets lifetime achievement award
Bill Gates, co-chair, Bill & Melinda Gates Foundation, gave away this award to Mazumdar-Shaw in New Delhi on Nov 17 at an event to mark the celebration of 108th Foundation Day of ICMR. She was also recognised for her philanthropic efforts and providing better healthcare to people in India and globally through cost-effective life-saving therapies.
Kiran Mazumdar Shaw settles alleged insider trading case with Sebi in Infosys matter
Shaw had delayed making the requisite disclosures with respect to change in her shareholding.
Biz leaders, experts to discuss corporate governance in 2-day summit
The two-day summit, to be held on November 21-22 in Mumbai, will witness the participation of all categories of stakeholders, including business leaders, regulators, corporate chieftains, directors, lawyers, chartered accountants, other professionals and board members.
A billion-dollar dream: Kiran Mazumdar-Shaw feels agriculture sector will be big in India, abroad
The Biocon CMD said that the agri sector comes with amazing technologies and big opportunities.
How trust deficit at multiple levels is hampering animal spirits and growth in India
India’s economy and businesses are facing many measurable, well-understood challenges. But an invisible crisis that is just as corrosive and harder to fix is underway: the erosion of trust. This is playing out at multiple levels.
Biocon’s $1-bn target for biologics biz achievable by FY22: Kiran Mazumdar Shaw
In the next 10 years, there is great opportunity for cos that want to play in biosimilars.
Kiran Mazumdar-Shaw meets Jack Ma in Singapore, says his journey inspires her
Both were in Singapore attending sessions on key issues impacting the world today, at a summit.
Biocon Q2 net profit at Rs 216 crore
Consolidated total income of the company stood at Rs 1,610.6 crore for the quarter under consideration.
Kiran Mazumdar Shaw seeks measures to save jobs in auto sector
Shaw's reaction on twitter came after automobile sale in India witnessed its worst-ever drop in August with despatches in all segments, including passenger vehicles and two-wheelers, plummeting to an all-time low.
5% GDP growth illustrates 'economic emergency': Kiran Mazumdar Shaw
Shaw, who heads the south-headquartered Biocon, said the economic growth data clearly suggests a fall in consumption which needs to be addressed.
FM response to Kiran Mazumdar Shaw’s tweet gets thumbs up from Biocon CMD
The Biocon CMD thanked the Finance Minister for the response on Twitter.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service